- Fmoc-Aph(Hor)-OH
-
- $150.00
-
2023-06-26
- CAS:1253282-31-3
- Min. Order: 10g
- Purity: more than 99.6%
- Supply Ability: 500kg/month
|
| | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine Basic information |
| Product Name: | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine | | Synonyms: | (S)-2-(Fmoc-amino)-3-[4-[(S)-2,6-dioxohexahydropyrimidine-4-carboxamido]phenyl]propanoic Acid;(2S)-3-{4-[(4S)-2,6-dioxo-1,3-diazinane-4-amido]phenyl}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid;N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((S)-2,6-dioxohexahydropyrimidine-4-carboxamido)phenyl)propanoic acid;Fmoc-D-Aph(D-H)-OH;(9H-Fluoren-9-yl)MethOxy]Carbonyl L-Aph(L-Hor)-OH;Fmoc-4-Aph(L-Hor);Fmoc-Aph(L-Hor)-OH | | CAS: | 1253282-31-3 | | MF: | C29H26N4O7 | | MW: | 542.54 | | EINECS: | | | Product Categories: | | | Mol File: | 1253282-31-3.mol | ![N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine Structure](CAS/20150408/GIF/1253282-31-3.gif) |
| | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine Chemical Properties |
| Melting point | >222°C (dec.) | | density | 1.412±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO (Slightly, Sonicated)Methanol (Slightly, Heated, Sonicated) | | pka | 3.77±0.10(Predicted) | | form | Solid | | color | White to Off-White | | InChIKey | TYZSMQUWFLKJFB-ZEQRLZLVSA-N | | SMILES | C(O)(=O)[C@H](CC1=CC=C(NC([C@@H]2CC(=O)NC(=O)N2)=O)C=C1)NC(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)=O | | CAS DataBase Reference | 1253282-31-3 |
| | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine Usage And Synthesis |
| Uses | Fmoc-Aph(Hor)-OH (CAS# 1253282-31-3) is an intermediate of degarelix, a pharmeceutical hormone used in the treatment of prostate cancer. Fmoc-Aph(Hor)-OH has been used as a building block in peptide elongation reactions. |
| | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine Preparation Products And Raw materials |
|